PlumX Metrics
Embed PlumX Metrics

The off-patent biological market in belgium: Is the health system creating a hurdle to fair market competition?

Pharmaceuticals, ISSN: 1424-8247, Vol: 14, Issue: 4
2021
  • 5
    Citations
  • 0
    Usage
  • 9
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and appraisal being mixed which results in poorly effective policy measures.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know